- Home
- MBOT vs TNYA Comparison
MBOT vs TNYA Comparison
Compare MBOT & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBOT | TNYA |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.7M | 157.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MBOT | TNYA |
|---|---|---|
| Price | $2.21 | $0.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $7.50 | $5.25 |
| AVG Volume (30 Days) | 2.6M | ★ 4.2M |
| Earning Date | 03-24-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,119.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.25 | $0.36 |
| 52 Week High | $4.67 | $2.35 |
Technical Indicators
Market Signals| Indicator | MBOT | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 60.99 | 38.57 |
| Support Level | $1.86 | $0.65 |
| Resistance Level | $2.37 | $0.86 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 78.57 | 10.22 |
Price Performance
Historical ComparisonAbout MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.